期刊文献+

Diagnostic accuracy of C-reactive protein for bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis

下载PDF
导出
摘要 Objective:The clinical diagnostic accuracy of C-reactive protein(CRP)for bacterial infections in acute exacerbation of chronic obstructive pulmonary disease(AECOPD)is still controversial.This study evaluated its accuracy through Meta-analysis.Methods:Studies on the diagnostic value of CRP for bacterial infections in AECOPD were searched form Web of Science,PubMed,Cochrane library,EMBASE,WANFANG DATA,CNKI and China Biology Medicine disc.The included studies were evaluated according to QUADAS-2 assessment tool.Stata 12.0 software was used for meta analyses to summarize the sensitivity and the specificity of the included studies,and the heterogeneity test was conducted.The symmetric receiver operating characteristic curves(SROC)was drawn and the area under the curve(AUC)was calculated,and the funnel plot was drawn to determine publication bias.Results:664 studies were initially identified,20 of which met the inclusion criteria(9 in English and 11 in Chinese).Meta-analysis results showed that the summary sensitivity and specificity of CRP in diagnosing bacterial infections in AECOPD were 0.84,95%CI(0.77-0.90)and 0.76,95%CI(0.67-0.82),respectively.The AUC of SROC was 0.87,95%CI(0.83-0.89).Conclusion:CRP has high accuracy,sensitivity and specificity in distinguishing AECOPD bacterial infections from non-bacterial infection.
出处 《Journal of Hainan Medical University》 2020年第9期51-55,共5页 海南医学院学报(英文版)
  • 相关文献

参考文献7

二级参考文献67

  • 1黄根牙,顾新元,唐利龙.C反应蛋白致动脉粥样硬化的作用[J].国际心血管病杂志,2008,35(6):363-366. 被引量:5
  • 2袁瑾懿,杨帆.美国2005《医院获得性肺炎治疗指南》[J].中国感染与化疗杂志,2006,6(6):420-423. 被引量:80
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8227
  • 4Sethi S. Pathogenesis and treatment of acute exacerbations of chronic ob- structive pulmonary disease[ J]. Semin Respir Crit Care Med,2005, 26 (2) : 192-203.
  • 5Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic anflam- marion, infection and sepsis : clinical utility and limitations [ J ]. Cfit Care Med,2008,36(2) : 941-952.
  • 6Schuetz P, Albrich W, Christ-Crain M, et al. Procalcitonin for guidance of antibiotic therapy[ J]. Expert Rev Anti Infect Ther,2010,8 (5) :575- 587.
  • 7Vestbo J, Hurd SS, Agustl AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease --CRDLD executive summary[J]. Am J Respir Crit Care Med, 2013, 187(4) :347 - 365.
  • 8Bafadhel M, McKenna S, Terry S, e* al. Acute exacerbations o{ COPD: identification of biological clusters and their biomarkers[J]. Am J Re- spir Crit Care Med,2011,184(6) :662 - 671.
  • 9Tofan F, Rahimi- Rad MH, Rasmi Y, et al. High sensitive C- reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease [ J 1. Pneumologia, 2012,61 (3) : 160 - 162.
  • 10Brightling CE. Biomarkers that predict and guide therapy for exacerba- tions of chronic obstructive pulmonary disease [J~. Ann Am Thorac Soc, 2013,10 (Suppl) :$214 - 219.

共引文献148

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部